<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T02:20:33Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2072/478657" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2072/478657</identifier><datestamp>2025-08-31T17:34:42Z</datestamp><setSpec>com_2072_98</setSpec><setSpec>col_2072_378192</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?</dc:title>
   <dc:creator>Arrobas Velilla, Teresa</dc:creator>
   <dc:creator>Guijarro, C.</dc:creator>
   <dc:creator>Campuzano Ruiz, R</dc:creator>
   <dc:creator>Rodríguez Piñero, M.</dc:creator>
   <dc:creator>Valderrama Marcos, J.F.</dc:creator>
   <dc:creator>Pérez Pérez, Antonio</dc:creator>
   <dc:creator>Botana López, M.A.</dc:creator>
   <dc:creator>Morais López, A.</dc:creator>
   <dc:creator>García Donaire, J.A.</dc:creator>
   <dc:creator>Obaya, J.C.</dc:creator>
   <dc:creator>Castilla Guerra, L.</dc:creator>
   <dc:creator>Pallares Carratalá, V.</dc:creator>
   <dc:creator>Egocheaga Cabello, I.</dc:creator>
   <dc:creator>Salgueira Lazo, M.</dc:creator>
   <dc:creator>Castellanos Rodrigo, M.M.</dc:creator>
   <dc:creator>Mostaza Prieto, J.M.</dc:creator>
   <dc:creator>Gómez Doblas, J.J.</dc:creator>
   <dc:creator>Buño Soto, A.</dc:creator>
   <dc:creator>Universitat Autònoma de Barcelona</dc:creator>
   <dc:subject>Apolipoprotein B</dc:subject>
   <dc:subject>Apolipoproteína B</dc:subject>
   <dc:subject>Biochemistry</dc:subject>
   <dc:subject>Bioquímica</dc:subject>
   <dc:subject>Cardiovascular disease</dc:subject>
   <dc:subject>Cholesterol</dc:subject>
   <dc:subject>Colesterol</dc:subject>
   <dc:subject>Consenso</dc:subject>
   <dc:subject>Consensus</dc:subject>
   <dc:subject>Enfermedades cardiovasculares</dc:subject>
   <dc:subject>Lipid panel</dc:subject>
   <dc:subject>Lipids</dc:subject>
   <dc:subject>Lipoprotein (a)</dc:subject>
   <dc:subject>Lipoproteína (a)</dc:subject>
   <dc:subject>Lípidos</dc:subject>
   <dc:subject>Panel de lípidos</dc:subject>
   <dc:subject>Triglicéridos</dc:subject>
   <dc:subject>Triglycerides</dc:subject>
   <dc:description>Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports.</dc:description>
   <dc:date>2023</dc:date>
   <dc:type>Article</dc:type>
   <dc:identifier>https://ddd.uab.cat/record/302847</dc:identifier>
   <dc:identifier>urn:10.1016/j.arteri.2022.10.002</dc:identifier>
   <dc:identifier>urn:oai:ddd.uab.cat:302847</dc:identifier>
   <dc:identifier>urn:scopus_id:85152432388</dc:identifier>
   <dc:identifier>urn:articleid:15781879v35n2p91</dc:identifier>
   <dc:identifier>urn:pmid:36925360</dc:identifier>
   <dc:identifier>urn:oai:egreta.uab.cat:publications/2d1025a9-ffda-4dfa-86a9-95ad62675a13</dc:identifier>
   <dc:identifier>urn:oai:egreta.uab.cat:publications/c8a7949a-e9fc-4aca-8c02-49224813a654</dc:identifier>
   <dc:identifier>urn:oai:egreta.uab.cat:publications/a4afa230-2911-4c9b-9f6e-4864f9393ddf</dc:identifier>
   <dc:identifier>urn:oai:egreta.uab.cat:publications/9becfef2-6c48-4205-bced-debb2c5a21b2</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:relation>Clinica e Investigacion en Arteriosclerosis ; Vol. 35 Núm. 2 (enero 2023), p. 91-100</dc:relation>
   <dc:rights>open access</dc:rights>
   <dc:rights>Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.</dc:rights>
   <dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher/>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>